Pharmacetical Newswire

Pharmaceutical News!

Press release distribution service
Pharmaceutical Links

Pharmanewswire.Com: Pharmaceutical News

Synthetic Gypsum Market Worth 1.80 Billion USD by 2023

 



(PharmaNewsWire.Com, May 28, 2019 ) The report "Synthetic Gypsum Market by Type (FGD gypsum, Citrogypsum, Fluorogypsum, Phoshogypsum), Application (Cement, Drywall, Soil amendment, Dental), and Region (Americas, Europe, Asia Pacific, and Middle East & Africa) - Global Forecast to 2023" published by MarketsandMarkets™, the market size is projected to grow from USD 1.42 Billion in 2018 to USD 1.80 Billion by 2023, at a CAGR of 4.82%.

Request for PDF Sample Report @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=55459398

The market is projected to witness significant growth over the next few years with the increasing demand for new constructions due to rapid urbanization and industrialization with large-scale investment in the commercial and infrastructural sectors. The rising demand for synthetic gypsum in emerging economies and the increasing inclination toward sustainable construction methods are increasing the reliance on modern construction materials, thus creating growth opportunities for the Synthetic Gypsum Market.

Drywall segment to gain maximum traction during the forecast period

The drywall segment is estimated to dominate the market in 2018 and is projected to be the fastest-growing application in the next five years. As a result of rapid urbanization and industrialization, this market is mostly driven by the surge in demand for new constructions across the world. The increasing public and private investments in construction applications of emerging economies in Asia Pacific, the Middle East, and South America drive the growth of this market.

The FGD gypsum segment, by type, is estimated to account for a large market share in 2018

FGD synthetic gypsum finds application in several sectors, which drives its demand. This segment dominates the Synthetic Gypsum Market and is projected to grow at a higher rate during the forecast period. FGD gypsum is used in the agriculture sector as a fertilizer to improve crop yield; it is added as a sulfur or calcium fertilizer in the soil. In the construction sector, it is used as a filler material in cement and plasters to enhance strengthening and reduce the setting time of concrete. It also finds application in the building & construction industry to make decorative panels and PoP structures. Hence, the FGD synthetic gypsum type accounted for a relatively larger share in Synthetic Gypsum Market among all other types.

Don't miss out on business opportunities in Synthetic Gypsum Market. Speak to Our Analyst and gain crucial industry insights that will help your business grow. https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=55459398

The Asia Pacific region accounted for the largest share of the Synthetic Gypsum Market in 2018

Asia Pacific contributes a major share in the global Synthetic Gypsum Market. Due to the increasing industrialization as well as the large population in China, Japan, and India, these countries are experiencing high demand for building & construction. The rapid urbanization in these countries demands faster and cheaper construction of buildings and facilities without compromising on quality. Additionally, the increasing government investments in infrastructural constructions provide the potential for growth of the Synthetic Gypsum Market in these countries.

The major players in the Synthetic Gypsum Market include USG Corporation (US), Lafarge Holcim (Switzerland), FEECO international (US), Delta Gypsum (US), National Gypsum (US), Synthetic Materials LLC (US), Constantia Building Products (US), and KNAUF GIPS (Germany). Other players include American Gypsum (US), PABCO Gypsum (US), British Gypsum (Europe), Georgia-Pacific (US), and Gyptec Ibčrica (Portugal).

Purchase the report @ https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=55459398

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.


MarketsandMarkets™

Mr. Shelly Singh

1-888-600-6441

raviraj.tak@marketsandmarkets.com

Source: EmailWire.Com

Source: EmailWire.com


Pharmaceutical Sponsors

Free Biotech & Pharmaceutical Magazines

Pharmacy Newswire Video Feed

Pharmaceutical & Biotech Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:

IronPort Provides Email Management and Analysis for a Premier Health Care Solutions Provider
Pharmaceutical & Medical Packaging News
Medical Laboratory Observer

No credit cards, coupons, or promo codes required. Try it today!

Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com, or contact us.
Copyright 2009 GroupWeb Media LLC
GroupWeb Media Network

Aviation-NewsWire | ArtNewsWire | Auction NewsWire | CRM NewsWire | ePhotoNewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | i-Homeland Security.Com | iMac-NewsWire.Com | i-Press-Release-Service | i-SoftwareNews.com | iT-NewsWire.Com
| i-TravelNewsWire.Com | MoneyNewsWire.Net | Movie-Stars-News.Com | MSNewsWire.Net | PharmaNewsWire.Com | Publishing-NewsWire.Com | RSSNewsWire.Net | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com | VoIPNewsWire.Net | XSportsWorld.Net
Pharmanewswire.com - Pharmaceutical Newswire and Press Release service of GroupWeb Media LLC